Endpoints News 19. Feb. 2026 J&J pauses patient recruitment in mid-stage trial of AC Immune’s Alzheimer’s drug
Endpoints News 19. Feb. 2026 J&J pauses patient recruitment in mid-stage trial of AC Immune’s Alzheimer’s drug
Endpoints News 18. Feb. 2026 Charles River highlights increase in demand as tariff uncertainties fade
Endpoints News 18. Feb. 2026 Novartis signs macrocyclic deal with Unnatural Products for $100M upfront
Endpoints News 18. Feb. 2026 Lilly's Zepbound, Taltz combo data in psoriasis and weight loss; Novartis bolsters Rhapsido results
Endpoints News 18. Feb. 2026 Lilly licenses CSL’s IL-6 immuno-inflammatory antibody for $100M upfront